GeoVax Labs (GOVX) EBIT Margin Growth (5y) (2015 - 2025)
GeoVax Labs (GOVX) EBIT Margin Growth (5y) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | GeoVax Labs | 2.88 Mn | -260,493.75 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -53,411.00 |
| Mar 31, 2025 | -24,707.00 |
| Dec 31, 2024 | -74,520.00 |
| Sep 30, 2024 | -8,205.00 |
| Jun 30, 2024 | -137,212.00 |
| Mar 31, 2022 | -279,270.00 |
| Dec 31, 2021 | -779,651.00 |
| Sep 30, 2021 | -631,051.00 |
| Jun 30, 2021 | -151,862.00 |
| Mar 31, 2021 | 130,808.00 |
| Dec 31, 2020 | -9,796.00 |
| Sep 30, 2020 | 56,214.00 |
| Jun 30, 2020 | 84,699.00 |
| Mar 31, 2020 | 59,527.00 |
| Dec 31, 2019 | 19,426.00 |
| Sep 30, 2019 | 3,214.00 |
| Jun 30, 2019 | 6,571.00 |
| Mar 31, 2019 | 19,974.00 |
| Dec 31, 2018 | 28,757.00 |
| Sep 30, 2018 | -17,197.00 |